The Salk Institute and Indivumed: Advancing Global Cancer Research Through Partnership

News   Jan 17, 2018 | Original story from The Salk Institute

 
The Salk Institute and Indivumed: Advancing Global Cancer Research Through Partnership

Salk's CSO Martin Hetzer, Cancer Center Director Reuben Shaw and Director of Business Development Tari Suprapto pictured with Indivumed's Founder and CEO Hartmut Juhl and Managing Director Andrew Deubler. Credit: Salk Institute

 
 
 

RELATED ARTICLES

New Subtype of Prostate Cancer

News

Researchers led by the University of Michigan Rogel Cancer Center have identified a new subtype of prostate cancer that occurs in about 7 percent of patients with advanced disease.

READ MORE

Biometric System Measures Brainwaves, Creates Brain Password

News

The “brain password” could have implications in banking, law enforcement, airport security and other areas.

READ MORE

Cryo-EM Reveals Interaction Between Major Drug Targets

News

For the first time, scientists have visualized the interaction between two critical components of the body's vast cellular communication network, a discovery that could lead to more effective medications with fewer side effects for conditions ranging from migraine to cancer.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy